Company Filing History:
Years Active: 2017
Title: Brian Kobmann: Innovator in Bacterial Mutants
Introduction
Brian Kobmann is a notable inventor based in Herlev, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of bacterial mutants with enhanced transformation efficiency. His work is crucial for advancing genetic engineering and microbial applications.
Latest Patents
Kobmann holds a patent titled "Bacterial mutants with improved transformation efficiency." This patent describes mutants that possess a disruption to an endogenous gene encoding a restriction modification system protein. The patent also outlines methods for producing these mutants, generating transformants using them, and producing polypeptides or fermentation products.
Career Highlights
Brian Kobmann is associated with Novozymes A/S, a leading company in the biotechnology sector. His role at Novozymes allows him to apply his innovative ideas in a practical setting, contributing to the company's mission of sustainable solutions through biotechnology.
Collaborations
Kobmann has worked alongside esteemed colleagues such as Steen Troels Joergensen and Torsten Bak Regueira. Their collaboration fosters a dynamic environment for research and development, enhancing the impact of their collective work.
Conclusion
Brian Kobmann's contributions to the field of biotechnology through his patent and work at Novozymes A/S highlight his role as an innovator. His research on bacterial mutants is paving the way for advancements in genetic engineering and microbial applications.